|
Novel Phosphorylation that Controls the Stability of Hypoxia-Inducible Factor 1 Alpha
A University of Arizona researcher has invented a polyclonal antibody against a novel phosphorylation site that is known to be correlated with increased tumor growth. Specifically, the antibody targets a phosphorylation site on HIF-1α, which is controlled by PIM kinases.
Background:
Anti-angiogenic therapy is a new and promising strategy for...
Published: 11/20/2024
|
Inventor(s): Noel Warfel
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Medical Devices > Diagnostic
|
